An experimental approach to the chemotherapy of melanoma.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Journal of Investigative Dermatology

• Publication date

  1980-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/1523-1747.EP12519812PMID 7351499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• STRUCTURAL ANALOGS OF L-GLUTAMIC ACID Γ-(4-HYDROXYANILIDE) AND Γ-(3,4-DIHYDROXYANILIDE) AS POTENTIAL AGENTS AGAINST MELANOMA

  1980cited by this paper
• Role of superoxide dismutase in cancer: a review.

  1979cited by this paper
• Levodopa and dopamine analogs: melanin precursors as antitumor agents in experimental human and murine leukemia.

  1979cited by this paper
• Levodopa and dopamine analogs: melanin precursors as antitumor agents in experimental human and murine leukemia.

  1979cited by this paper
• Structural analogues of L-glutamic Acid gamma-(4-hydroxyanilide) and gamma-(3,4-dihydroxyanilde) as potential agents against melanoma.

  1979cited by this paper
• L-Dopa methyl ester: prolongation of survival of neuroblastoma-bearing mice after treatment.

  1978cited by this paper
• 5,6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity

  1978cited by this paper
• Dopamine: a novel antitumor agent active against B-16 melanoma in vivo.

  1978cited by this paper
• Enhancement of L-dopa incorporation into melanoma by dopa decarboxylase inhibition.

  1978cited by this paper
• gamma-L-Glutaminyl-4-hydroxybenzene, an inducer of cryptobiosis in Agaricus bisporus and a source of specific metabolic inhibitors for melanogenic cells.

  1977cited by this paper
• L-Dopa methyl ester as a new antitumour agent

  1977cited by this paper
• L-dopa: selective toxicity for melanoma cells in vitro.

  1977cited by this paper
• Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro.

  1977cited by this paper
• Factors regulating growth and pigmentation of melanoma cells.

  1976cited by this paper
• Maturation and differentiation of B16 melanoma cells induced by theophylline treatment.

  1975cited by this paper
• Molecular biology of pigment cells. Molecular controls in mammalian pigmentation.

  1973cited by this paper
• Effects of alpha-MSH on melanogenesis and tyrosinase of B-16 melanoma.

  1972cited by this paper
• Isolation from the mushroom Agaricus bisporus and chemical synthesis of gamma-L-glutaminyl-4-hydroxybenzene.

  1971cited by this paper
• On the etiology of vitiligo and gray hair.

  1971cited by this paper
• Depigmentation of skin with 4-isopropylcatechol, mercaptoamines, and other compounds.

  1968cited by this paper
• Mammalian melanin biosynthesis.

  1965cited by this paper
• THE CYTOTOXICITY OF MELANIN PRECURSORS *

  1963cited by this paper
• THE CYTOTOXICITY OF MELANIN PRECURSORS *

  1963cited by this paper

• Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development

  2022influential citation
• Parkinson’s Disease and Melanoma: Co-Occurrence and Mechanisms

  2018cites this paper
• A REVIEW OF ETHNOBOTANY , PHYTOCHEMISTRY , ANTIVIRAL AND CYTOTOXIC / ANTICANCER POTENTIAL OF MORUS ALBA LINN

  2016cites this paper
• Catalysis and inactivation of tyrosinase in its action on hydroxyhydroquinone

  2014cites this paper
• The association between Parkinson's disease and melanoma

  2011cites this paper
• Tyrosinase activated melanoma prodrugs.

  2009cites this paper
• Structure-Activity Relationships Defining the Cytotoxicity of Catechol Analogues against Human Malignant Melanoma 1

  2006cites this paper
• Selective Cytotoxicity of 4-5'-Cysteaminylphenol on Follicular Melanocytes of the Black Mouse: Rational Basis for Its Application to Melanoma Chemotherapy1

  2006cites this paper
• Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature

  2006cites this paper
• DNA Damage and Selective Toxicity of Dopa and Ascorbate : Copper in Human Melanoma Cells 1

  2006cites this paper
• New prodrugs derived from 6-aminodopamine and 4-aminophenol as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT).

  2005cites this paper
• In vivo antimelanoma effects of 4-S-cysteaminylphenol, a newly synthesized therapeutic agent specific to melanoma

  2005cites this paper
• Identification of three indolic compounds in a pigmented-melanoma cell-culture supernatant by gas chromatography-mass spectrometry

  2004cites this paper
• Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect

  2004cites this paper
• Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells

  2004cites this paper
• Tyrosinase-mediated formation of a reactive quinone from the depigmenting agents, 4-tert-butylphenol and 4-tert-butylcatechol.

  2000cites this paper
• Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.

  1997cites this paper
• Determination of the L-DOPA/L-tyrosine ratio in human plasma by high-performance liquid chromatography. Usefulness as a marker in metastatic malignant melanoma.

  1997cites this paper
• [Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma].

  1996cites this paper
• Oxidative damage caused by free radicals produced during catecholamine autoxidation: protective effects of O-methylation and melatonin.

  1996cites this paper
• Levodopa und malignes Melanom – Fallbericht und Literaturübersicht Ein Beitrag zur Frage des Kausalzusammenhanges zwischen Levodopa und der Entwicklung eines malignen Melanoms

  1996cites this paper
• Induction of cytotoxicity in melanoma cells through inhibition of catechol-O-methyltransferase.

  1995cites this paper
• Some aspects of melanin formation of melanocytes cultured on collagen-coated microcarrier beads.

  1995cites this paper
• The inherent cytotoxicity of melanin precursors: a revision.

  1994cites this paper
• Safety of Long‐term Levodopa Therapy in Malignant Melanoma

  1994cites this paper
• Catechol-O-methyltransferase as a target for melanoma destruction?

  1994cites this paper
• Antimelanoma activity of chloroquine, an antimalarial agent with high affinity for melanin.

  1993cites this paper
• Interaction of alpha-melanocyte-stimulating hormone with its receptor

  1993cites this paper
• Levodopa, melanoma, and Parkinson's disease

  1993cites this paper
• Cellular and molecular biology of melanoma.

  1992cites this paper
• Induction of tyrosinase in human melanoma cells by L-tyrosine phosphate and cytochalasin D.

  1992cites this paper
• Cellular and molecular biology of melanoma.

  1992cites this paper
• Progress and Prospects for Therapeutic Targeting Strategies for Disseminated Melanoma

  1992cites this paper
• Diagnosis and Management of Melanoma in Clinical Practice

  1992cites this paper
• The use of L-dopa and carbidopa in metastatic malignant melanoma.

  1991cites this paper
• Tyrosine transport in a human melanoma cell line as a basis for selective transport of cytotoxic analogues.

  1991cites this paper
• Possible relationship between abnormal melanosome structure and cytotoxic phenomena in malignant melanoma.

  1991cites this paper
• Melanogenesis: a realistic target for antimelanoma therapy?

  1991cites this paper
• Does melanin affect the low LET radiation response of Cloudman S91 mouse melanoma cell lines?

  1991cites this paper
• Mechanism of growth inhibition of melanoma cells by 4-S-cysteaminylphenol and its analogues.

  1990cites this paper
• Effect of pH on the oxidation pathway of alpha-methyldopa catalysed by tyrosinase.

  1990cites this paper
• 4-S-cysteaminylphenol and its analogues as substrates for tyrosinase and monoamine oxidase.

  1990cites this paper
• Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo.

  1990cites this paper
• Stimulation of tyrosinase by dihydroxy phenyl derivatives.

  1989cites this paper
• The synthesis of 4-S-cysteinyl-[U-14C]phenol, an experimental antimelanoma agent.

  1989cites this paper
• Phenolic melanin precursors provide a rational approach to the design of antitumor agents for melanoma.

  1989cites this paper
• Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.

  1989cites this paper
• Specific incorporation of 4-S-cysteinylphenol into human melanoma cells.

  1988cites this paper
• Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma.

  1988cites this paper
• Radicals in Melanin Biochemistry a

  1988cites this paper
• Approaches for drug development in treatment of advanced melanoma.

  1988cites this paper
• Structure-activity relationships defining the cytotoxicity of catechol analogues against human malignant melanoma.

  1988cites this paper
• Chemotherapie beim metastasierten malignen Melanom

  1988cites this paper
• Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes.

  1987cites this paper
• Growth inhibition of melanoma cells by N-protected dopa derivatives.

  1987cites this paper
• Semiquinone anion radicals from addition of amino acids, peptides, and proteins to quinones derived from oxidation of catechols and catecholamines. An ESR spin stabilization study.

  1987cites this paper
• Comparative cytotoxicity of phenols in vitro.

  1987cites this paper
• Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy.

  1987cites this paper
• Mechanism of antitumoral activity of catechols in culture.

  1987cites this paper
• Tyrosinase-catalyzed oxidation of dopa and related catechol(amine)s: a kinetic electron spin resonance investigation using spin-stabilization and spin label oximetry.

  1987cites this paper
• Histological localization of 4-S-cysteinylphenol in melanoma-bearing mice.

  1987cites this paper
• Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes

  1987cites this paper
• Cyclic amines are selective cytotoxic agents for pigmented cells.

  1986cites this paper
• Cloning and expression of cDNA encoding mouse tyrosinase.

  1986cites this paper
• Study of α-methyldopa oxidation by tyrosinase

  1986cites this paper
• Cyclic amines are selective cytotoxic agents for pigmented cells

  1986cites this paper
• Study of alpha-methyldopa oxidation by tyrosinase.

  1986cites this paper
• Accumulation of chlorpromazine and thiouracil by human melanoma cells in culture.

  1986cites this paper
• Modification of dopa toxicity in human tumour cells.

  1985cites this paper
• Radicals and melanomas.

  1985cites this paper
• Resistance to Amino Acid Analogs

  1984cites this paper
• Experimental Chemotherapy of Melanoma

  1984cites this paper
• The chemotherapy of malignant melanoma.

  1983cites this paper
• The chemotherapy of malignant melanoma.

  1983cites this paper
• 3,4-Dihydroxybenzylamine: an improved dopamine analog cytotoxic for melanoma cells in part through oxidation products inhibitory to dna polymerase.

  1983cites this paper
• The effect of divalent cations on Cloudman melanoma cells.

  1983cites this paper
• The mechanism of toxicity of 5-S-cysteinyldopa to tumour cells. Hydrogen peroxide as a mediator of cytotoxicity.

  1983cites this paper
• Chemotherapy of melanoma

  1982cites this paper
• Chemotherapy of malignant melanoma.

  1982cites this paper
• The biosynthesis of mammalian melanin.

  1982cites this paper
• DNA damage and selective toxicity of dopa and ascorbate:copper in human melanoma cells.

  1982cites this paper
• Affinity directed reactions of 3-trimethylaminomethyl catechol with the acetylcholine receptor from Torpedo californica.

  1982cites this paper
• Chemotherapie maligner Melanome

  1981cites this paper
• An ultrastructural study of albinistic B-14 melanoma cells.

  1981cites this paper
• Inhibition of clonogenic growth of melanoma cells by combination of melanocyte stimulating hormone and theophylline.

  1981cites this paper
• The modulation of mouse melanoma cell colony formation in soft agar by dopaminergic agents

  1981cites this paper
• New regulators of melanin biosynthesis and the autodestruction of melanoma cells

  1980cites this paper